Document Detail


The benefit of oestrogens and progestogens in postnatal depression.
MedLine Citation:
PMID:  12881067     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Postnatal depression, with a prevalence of at least 10%, is a common complication of the puerperium. The aetiology is unclear, specific diagnostic criteria cannot be drawn and the treatment options are limited. As hormones are thought to contribute to its pathophysiology, the supplementation with either progesterone or oestrogen might be of prophylactic and/or therapeutic value in postnatal depression. Research into hormonal prophylaxis and treatment of postnatal depression (PND) is limited. This review article is aimed at exploring the evidence available regarding the use of oestrogen and progesterone in postnatal depression. A search of electronic databases Medline, Psychinfo, Embase and published books from 1970 to 2002 was carried out. The search strategy was limited to the English language. Of 193 articles, 30 were chosen and all 30 copies were identified and analysed critically. Prophylactic and treatment value were separately analysed for both oestrogen and progesterone. Some uncontrolled studies by Dalton (1982, 1985) report the benefit of progesterone in preventing postnatal depression. The value of oestrogen in preventing and treating this disorder is suggested by some articles but the methodological shortcomings in these studies make the study results unreliable. In addition, the use of oestrogen in the postnatal period may have significant side effects. Use of synthetic progesterone is associated with depression in the postnatal period and should be used with caution. Oestrogen therapy may be of modest value in severe postnatal depression.
Authors:
J Karuppaswamy; R Vlies
Related Documents :
17728677 - Evidence based medicine: analysis of scheuermann kyphosis.
24467817 - Hypomania and mania related to dopamine replacement therapy in parkinson's disease.
23070307 - Feeling blue or turquoise? emotional differentiation in major depressive disorder.
24673497 - Efficacy and safety of memantine in patients with moderate-to-severe alzheimer's diseas...
10327507 - Active back school: prophylactic management for low back pain. a randomized, controlled...
20881017 - The adas-cog in alzheimer's disease clinical trials: psychometric evaluation of the sum...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology     Volume:  23     ISSN:  0144-3615     ISO Abbreviation:  J Obstet Gynaecol     Publication Date:  2003 Jul 
Date Detail:
Created Date:  2003-07-25     Completed Date:  2003-10-01     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8309140     Medline TA:  J Obstet Gynaecol     Country:  England    
Other Details:
Languages:  eng     Pagination:  341-6     Citation Subset:  IM    
Affiliation:
Wrexham Maelor Hospital, UK. rajaga2000@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antidepressive Agents / therapeutic use
Clinical Trials as Topic
Depression, Postpartum / drug therapy*,  etiology,  prevention & control
Estrogens / therapeutic use*
Female
Humans
Pregnancy
Progesterone / therapeutic use*
Progesterone Congeners / adverse effects
Chemical
Reg. No./Substance:
0/Antidepressive Agents; 0/Estrogens; 0/Progesterone Congeners; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Computer-assisted instruction: guiding learning through a key features approach in a community-based...
Next Document:  Ultracision in gynaecological laparoscopic surgery.